Endothelial cell metabolism

G Eelen, P de Zeeuw, L Treps, U Harjes… - Physiological …, 2018 - journals.physiology.org
Endothelial cells (ECs) are more than inert blood vessel lining material. Instead, they are
active players in the formation of new blood vessels (angiogenesis) both in health and (life …

[HTML][HTML] Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS?

CA Meza, JD La Favor, DH Kim… - International journal of …, 2019 - mdpi.com
NADPH oxidases (NOX) are enzyme complexes that have received much attention as key
molecules in the development of vascular dysfunction. NOX have the primary function of …

Mechanistic links between obesity, diabetes, and blood pressure: role of perivascular adipose tissue

SN Saxton, BJ Clark, SB Withers… - Physiological …, 2019 - journals.physiology.org
Obesity is increasingly prevalent and is associated with substantial cardiovascular risk.
Adipose tissue distribution and morphology play a key role in determining the degree of …

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I

MA Creager, TF Lüscher… - Circulation, 2003 - Am Heart Assoc
oxygen species (such as superoxide anion) that inactivate NO to form peroxynitrite. 27, 28
Hyperglycemia may initiate this process by increasing superoxide anion production via the …

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

HO Steinberg, H Chaker, R Leaming… - The Journal of …, 1996 - Am Soc Clin Investig
To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent
vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we …

Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders

A Janus, E Szahidewicz-Krupska… - Mediators of …, 2016 - Wiley Online Library
Insulin resistance and other risk factors for atherosclerosis, such as hypertension and
hypercholesterolemia, promote endothelial dysfunction and lead to development of …

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

TF Luscher, M Barton - Circulation, 2000 - Am Heart Assoc
The 21-amino acid peptide endothelin-1 (ET-1) is the predominant isoform of the endothelin
peptide family, which includes ET-2, ET-3, and ET-4. It exerts various biological effects …

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

E Cersosimo, RA DeFronzo - Diabetes/metabolism research …, 2006 - Wiley Online Library
Cardiovascular disease affects approximately 60% of the adult population over the age of 65
and represents the number one cause of death in the United States. Coronary …

[HTML][HTML] Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity

W Bakker, EC Eringa, P Sipkema… - Cell and tissue …, 2009 - Springer
Endothelial dysfunction comprises a number of functional alterations in the vascular
endothelium that are associated with diabetes and cardiovascular disease, including …

Cellular and molecular mechanisms of endothelial dysfunction in diabetes

AC Roberts, KE Porter - Diabetes and Vascular Disease …, 2013 - journals.sagepub.com
In healthy individuals, the vascular endothelium regulates an intricate balance of factors that
maintain vascular homeostasis and normal arterial function. Functional disruption of the …